Labcorp beats quarterly estimates on strong testing demand
Labcorp beat Wall Street expectations for first-quarter profit on Thursday, as growing demand for specialty tests boosted sales at its diagnostics business.
Labcorp beat Wall Street expectations for first-quarter profit on Thursday, as growing demand for specialty tests boosted sales at its diagnostics business.
AUA 2024 non-invasive bladder cancer, post hoc analysis of the ATLAS trial, primary chemoablation with UGN-102 in patients with new or recurrent low-grade, intermediate-risk non-muscle…
AUA 2024 non-invasive bladder cancer, artificial intelligence-powered pathology assay for predicting response to intravesical BCG, non-muscle invasive bladder cancer (NMIBC), CHAI assay.
AUA 2024, renal cell carcinoma (RCC), kidney cancer, immune checkpoint blockade (ICB), Primary Tumor, Response to Immune Checkpoint Blockade in Primary Tumor, Radiographic and Radiomic…
AUA 2024, upper tract urothelial carcinoma (UTUC), Computer Vision Analysis of Upper Tract Urothelial Carcinoma, flexible ureteroscopy (fURS), classifying tumor grade, area under the receiver…
AUA 2024 artificial intelligence biomarkers, BCG-treated patients with non-muscle invasive bladder cancer, bladder cancer, bladder cancer treatment.
The DEA is allowing annual and semi-annual production quotas for Schedule II drugs, after it became clear quarterly quotas would worsen shortages.
Three years ago, Moderna invested part of its vaccine windfall into a new gene-editing startup, Metagenomi. Now it’s backing out.
The current approval is based on the VOLTAIRE-HCLF clinical trial, which examined the bioavailability of high-concentration (100 mg/mL) and low-concentration (50 mg/mL) formulations of adalimumab-adbm.
Yemen’s Iran-aligned Houthi militia, which has disrupted global shipping to display its support for Palestinians in the Gaza conflict, is now offering a place for…
AUA 2024 upper tract transitional cell carcinoma, efficacy and safety of padeliporfin vascular targeted photodynamic therapy, low-grade upper tract urothelial carcinoma, ENdoluminal LIGHT activated treatment…